ONCOLOGY

Ovarian Cancer Screening and Early Detection

Jan 31, 2017 by in ONCOLOGY Comments Off on Ovarian Cancer Screening and Early Detection

Biomarker Description Method Reference CA 15-3 Tumor antigen Serum ELISA Woolas et al. [41] CA 19-9 Tumor antigen Serum ELISA Woolas et al. [41] TAG-72 Tumor antigen Serum ELISA Woolas…

read more

Management of Patients with Early-Stage Ovarian Cancer

Jan 31, 2017 by in ONCOLOGY Comments Off on Management of Patients with Early-Stage Ovarian Cancer

Professional group Recommendation US Preventive Services Task Force Does not recommend routine screening, concluding that “the potential harms outweigh the potential benefits” American Cancer Society Does not recommend routine screening;…

read more

Psychological Aspects of Hereditary and Non-hereditary Ovarian Cancer

Jan 31, 2017 by in ONCOLOGY Comments Off on Psychological Aspects of Hereditary and Non-hereditary Ovarian Cancer

Level of evidence Factor Most frequently observed observation Strong Age Younger age—more distress Disease stage More advanced disease—more distress Time since diagnosis Shorter—more distress Disability status Worse—more distress Physical symptoms…

read more

Genetic Risks of Ovarian Cancer

Jan 31, 2017 by in ONCOLOGY Comments Off on Genetic Risks of Ovarian Cancer

Syndrome Manifestations Inheritance Gene(s) Reference Hereditary breast and ovarian cancer Early-onset breast or ovarian cancer, multiple primary cancers, cancer in several generations, male breast cancer AD BRCA1 [19] BRCA2 [20]…

read more

Management of Hereditary Ovarian–Breast Cancer

Jan 31, 2017 by in ONCOLOGY Comments Off on Management of Hereditary Ovarian–Breast Cancer

Established risk factors Possible risk factors Suspected risk factors Age Early age at menarche Hormonal replacement therapy Family history – genetics Late age at menopause Dietary fat Nulliparity Infertility Obesity…

read more

Epidemiology of Ovarian Cancer: An Update

Jan 31, 2017 by in ONCOLOGY Comments Off on Epidemiology of Ovarian Cancer: An Update

Fig. 1.1 Worldwide ovarian cancer incidence and mortality rates. Rates are per 100,000 and represent age-standardized rates according to the world standard population (ASR (W)) (From the International Agency for…

read more

Strategies for the Management of Ovarian Cancer

Jan 31, 2017 by in ONCOLOGY Comments Off on Strategies for the Management of Ovarian Cancer

9. Eisenhauer EL, Abu-Rustum NR, Sonoda Y, Levine DA, Poynor EA, Aghajanian C, et al. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients…

read more

Apoptosis Induction and Regulation

Jan 28, 2017 by in ONCOLOGY Comments Off on Apoptosis Induction and Regulation

(1) Institut Bergonié, Bordeaux, France   Abstract Apoptosis is one of the main modalities of cell death, so important that it has outshined all others that only begin to be…

read more

Cell Cycle Control

Jan 28, 2017 by in ONCOLOGY Comments Off on Cell Cycle Control

(1) Institut Bergonié, Bordeaux, France   Abstract Cell cycle consists of the sequential events occurring between the emergence of a new cell and that of the two daughter cells generated…

read more

Signalling by Oxygen and Nitric Oxide

Jan 28, 2017 by in ONCOLOGY Comments Off on Signalling by Oxygen and Nitric Oxide

(1) Institut Bergonié, Bordeaux, France   Abstract Oxygen is, first of all, the combustive agent required for life and the provider of energy required by all heterotrophic organisms, those which…

read more
Get Clinical Tree app for offline access